First-pass extracted concept

KDM7A-TLR8 axis

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The paper presents the KDM7A-TLR8 axis as a mechanistic pathway that restrains profibrotic macrophage polarization. It is discussed as a potential therapeutic target in fibrotic disorders.

Source 1DOI PubMed

What problem it solves

It helps explain how epigenetic regulation can suppress disease-driving macrophage states in fibrosis.

Source 1DOI PubMed

Evidence Snippets

These findings uncover an epigenetic mechanism restraining disease-driving macrophage states and suggest the KDM7A-TLR8 axis as a potential therapeutic target in fibrotic disorders.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1age associationsupports2026Source 1DOI PubMed

Macrophage Kdm7a and Tlr8 expression declines with age in male mice.

Quoted textsource-backed

Notably, macrophage Kdm7a and Tlr8 expression declines with age in male mice, consistent with clinical risk patterns.

Claim 2mechanismsupports2026Source 1DOI PubMed

TLR8 suppresses fibrotic macrophage polarization and its expression is regulated by KDM7A via H3K27me2 at its enhancer.

Quoted textsource-backed

Mechanistically, we identify toll-like receptor 8 (TLR8) as a suppressor of Fib-Mac polarization whose expression is regulated by KDM7A via the repressive mark H3K27me2 at its enhancer.

Claim 3therapeutic implicationsupports2026Source 1DOI PubMed

The KDM7A-TLR8 axis is suggested as a potential therapeutic target in fibrotic disorders.

Quoted textsource-backed

These findings uncover an epigenetic mechanism restraining disease-driving macrophage states and suggest the KDM7A-TLR8 axis as a potential therapeutic target in fibrotic disorders.